Bone Biologics Corporation (BBLG) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Bone Biologics Corporation (BBLG) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $2.4M, listed on NASDAQ, employing roughly 2 people, carrying a beta of 0.53 to the broader market. Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Led by Jeffrey Frelick, public since 2021-10-13.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for BBLG as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.